PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.65%
Negative revenue growth while MTDR stands at 8.89%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-22.33%
Negative gross profit growth while MTDR is at 15.40%. Joel Greenblatt would examine cost competitiveness or demand decline.
-27.12%
Negative EBIT growth while MTDR is at 17.40%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-27.12%
Negative operating income growth while MTDR is at 17.40%. Joel Greenblatt would press for urgent turnaround measures.
0.59%
Net income growth under 50% of MTDR's 18.09%. Michael Burry would suspect the firm is falling well behind a key competitor.
2.40%
EPS growth under 50% of MTDR's 12.96%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
2.42%
Diluted EPS growth under 50% of MTDR's 13.66%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-1.30%
Share reduction while MTDR is at 4.23%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.54%
Reduced diluted shares while MTDR is at 3.86%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.12%
Dividend reduction while MTDR stands at 0.09%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
52.98%
OCF growth above 1.5x MTDR's 26.54%. David Dodd would confirm a clear edge in underlying cash generation.
480.44%
FCF growth above 1.5x MTDR's 247.18%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-22.38%
Negative 10Y revenue/share CAGR while MTDR stands at 416.64%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
11.78%
5Y revenue/share CAGR under 50% of MTDR's 230.53%. Michael Burry would suspect a significant competitive gap or product weakness.
27.55%
3Y revenue/share CAGR under 50% of MTDR's 123.95%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-26.83%
Negative 10Y OCF/share CAGR while MTDR stands at 299.40%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
15.45%
Below 50% of MTDR's 309.51%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
31.03%
3Y OCF/share CAGR under 50% of MTDR's 114.94%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-30.15%
Negative 10Y net income/share CAGR while MTDR is at 589.33%. Joel Greenblatt sees a major red flag in long-term profit erosion.
4.99%
Below 50% of MTDR's 481.49%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
261.68%
3Y net income/share CAGR above 1.5x MTDR's 102.19%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-15.54%
Negative equity/share CAGR over 10 years while MTDR stands at 223.11%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
7.00%
Below 50% of MTDR's 149.17%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
155.92%
3Y equity/share CAGR at 75-90% of MTDR's 192.97%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
-12.18%
Cut dividends over 10 years while MTDR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
227.32%
Dividend/share CAGR of 227.32% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
207.52%
Below 50% of MTDR's 699.74%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-2.00%
Firm’s AR is declining while MTDR shows 5.09%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-0.13%
Negative asset growth while MTDR invests at 3.54%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.97%
BV/share growth above 1.5x MTDR's 0.48%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.69%
We’re deleveraging while MTDR stands at 0.51%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-14.44%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.